839 pharmacies Dashenlin accepted

In the first three quarters of this year, Dashenlin had 29 investment mergers and acquisitions, involving a total of 839 stores

20 new M&A projects signed

On October 28, Dashenlin Pharmaceutical Group Co.

Dashenlin has 29 major investment mergers and acquisitions in the same industry this year.

The details of the 20 newly signed M&A projects this year are as follows:

Revenue in the third quarter was 4.

The revenue of Dashenlin Pharmaceutical’s retail business accounted for 93.

From the category point of view, the fastest growth in the first three quarters of 2021 is the Chinese and Western patent medicines, with a growth rate of 28.

Retail has always been a strong sector of Dashenlin.

On the other hand, despite the relatively low gross profit, the wholesale industry will not be ignored

Net increase of 1,590 stores in 9 months

As of September 30, Dashenlin had a total of 7,610 stores (including 738 franchise stores), with a total operating area of ​​605,000 square meters (excluding franchise store area)

From the perspective of regional distribution, South China is the well-known "hometown" of the large ginseng forest.

In general, the development of Dashenlin in various regions is basically balanced, and the growth rate in the Northeast, North China, Northwest, and Southwest regions is mainly due to the sales growth caused by store mergers and acquisitions

Guangdong and Guangxi have the highest level of effectiveness

During the reporting period, the effective monthly average effective monthly efficiency of Dashenlin's national direct-operated stores was 2,300 yuan/square meter

In terms of regions, southern China (including Guangdong and Guangxi) has the highest average monthly average efficiency, reaching 2,455 yuan per square meter, which is also the only area above the average; Eastern China (including Jiangxi, Zhejiang, Fujian, and Jiangsu) has the highest monthly average efficiency.